20 Matching Annotations
  1. Apr 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13063715/
  3. Feb 2026
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Addition of ipatasertib to dual anti-HER2 maintenance therapy in HER2-positive metastatic breast tumors with PIK3CA mutations: the phase 1b SOLTI-1507 IPATHER trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12869161/
  5. Dec 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12707859/
  7. Nov 2025
  8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Oncolytic measles virotherapy encoding the neutrophil activating protein (MV-s-NAP) is effective in synovial sarcoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12605261/
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12589053/
  10. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Tumor microRNA signatures associate with stage II/III melanoma patient outcomes
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12588674/
  11. Sep 2025
  12. 52.53.155.43 52.53.155.43
    1-s2.0-S2950329925001316-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/726d5e6775ea08a0ad2c07d3669773572ba926a8/1-s2.0-S2950329925001316-main-html.html
  13. pubs.acs.org pubs.acs.org
    Multiomic Analysis Links Neighborhood Disadvantage to Inflammatory Proteins and Tumorigenic Markers in ER+ Breast Cancer Plasma and Tumor Samples
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/full/10.1021/acs.jproteome.5c00447
  14. Jul 2025
  15. www.thelancet.com www.thelancet.com
    Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/ebiom/article/PIIS2352-3964(25)00267-1/abstract
  16. Jun 2025
  17. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12130801/
  18. May 2025
  19. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/cecc3cebd3eaad6ba83c59062e60c02fe1b97fdf/PDF-html.html
  20. www.sciencedirect.com www.sciencedirect.com
    Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396425001781
  21. Apr 2025
  22. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11995005/
  23. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Elacestrant in Women with Estrogen Receptor–Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11959270/
  24. Feb 2025
  25. link.springer.com link.springer.com
    The integrative genomic and functional immunological analyses of colorectal cancer initiating cells to modulate stemness properties and the susceptibility to immune responses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1186/s12967-025-06176-0
  26. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11821485/
  27. Jan 2025
  28. www.sciencedirect.com www.sciencedirect.com
    A microscopy-based screen identifies cellular kinases modulating mitochondrial translation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124724014943
  29. Dec 2024
  30. www.sciencedirect.com www.sciencedirect.com
    Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379124006232
  31. Nov 2023
  32. www.sciencedirect.com www.sciencedirect.com
    The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723012974
  33. Oct 2023
  34. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10591065/